Thrivent Financial for Lutherans cut its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 8.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 582,706 shares of the conglomerate’s stock after selling 51,825 shares during the period. Thrivent Financial for Lutherans’ holdings in Danaher were worth $162,003,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in DHR. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher during the 2nd quarter worth approximately $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher during the second quarter worth $25,000. MFA Wealth Advisors LLC bought a new stake in shares of Danaher in the second quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in shares of Danaher in the second quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP bought a new position in Danaher during the first quarter worth about $55,000. Institutional investors own 79.05% of the company’s stock.
Insider Activity
In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Danaher
Danaher Stock Performance
Shares of DHR stock opened at $230.50 on Friday. The firm has a market capitalization of $166.49 billion, a price-to-earnings ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business’s 50-day moving average price is $262.20 and its 200-day moving average price is $260.47. Danaher Co. has a 12 month low of $206.30 and a 12 month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the company earned $2.02 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts forecast that Danaher Co. will post 7.51 EPS for the current year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Differences Between Momentum Investing and Long Term Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The 3 Best Blue-Chip Stocks to Buy Now
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 5 discounted opportunities for dividend growth investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.